Drug makers trim prices for health overhaul

New York Times, June 22, 2009
The pharmaceutical industry agreed to reduce Medicare drug costs, as medical-industry groups accept cuts now in an apparent effort to stave off potentially more-burdensome givebacks under the Democrats' health-overhaul plan. Drug makers outlined a proposal to forgo $80 billion in revenue over a decade, largely by covering more of the cost of brand-name prescription drugs under Medicare. That would make up part of the $313 billion in government health-spending cuts that President Obama has proposed over a decade to help pay for the overhaul plan.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.